$RMD
RESMED INC Stock $rmd

$rmd Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-K Financial Statement

#000094381921000017 Filed on August 17, 2021

Income Statement

Concept	2021 Q2	2021	2020 Q2
Revenue	$876.1M	$3.197B	$770.3M
YoY Change	13.74%	8.11%	9.26%
Cost Of Revenue	$385.4M	$1.358B	$321.0M
YoY Change	20.06%	9.56%	6.12%
Gross Profit	$490.7M	$1.839B	$449.4M
YoY Change	9.19%	7.06%	11.68%
Gross Profit Margin	56.01%	57.53%	58.34%
Selling, General & Admin	$181.5M	$670.4M	$165.4M
YoY Change	9.72%	-0.93%	-3.61%
% of Gross Profit	36.98%	36.45%	36.8%
Research & Development	$59.88M	$225.3M	$52.50M
YoY Change	14.05%	11.56%	2.74%
% of Gross Profit	12.2%	12.25%	11.68%
Depreciation & Amortization	$36.76M	$156.8M	$38.60M
YoY Change	-4.77%	1.23%	-9.39%
% of Gross Profit	7.49%	8.52%	8.59%
Operating Expenses	$249.1M	$935.4M	$226.1M
YoY Change	10.15%	3.01%	-2.04%
Operating Profit	$241.6M	$903.7M	$223.3M
YoY Change	8.21%	11.61%	30.13%
Interest Expense	-$6.596M	$23.99M	-$14.90M
YoY Change	-55.73%	-40.59%	-20.32%
% of Operating Profit	-2.73%	2.65%	-6.67%
Other Income/Expense, Net	$4.169M	-$20.02M	$3.800M
YoY Change	9.71%	-73.86%	-157.58%
Pretax Income	$239.2M	$883.7M	$212.1M
YoY Change	12.78%	20.54%	121.4%
Income Tax	$44.11M	$409.2M	$34.30M
% Of Pretax Income	18.44%	46.3%	16.17%
Net Earnings	$195.1M	$474.5M	$177.8M
YoY Change	9.73%	-23.67%	158.43%
Net Earnings / Revenue	22.27%	14.84%	23.08%
Basic Earnings Per Share		$3.27
Diluted Earnings Per Share	$1.331M	$3.24	$1.217M
COMMON SHARES
Basic Shares Outstanding	145.5M	145.3M shares	144.7M
Diluted Shares Outstanding		146.5M shares

Balance Sheet

Concept	2021 Q2	2021	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$295.3M	$295.3M	$463.2M
YoY Change	-36.25%	-36.25%	214.89%
Cash & Equivalents	$295.3M	$295.3M	$463.2M
Short-Term Investments
Other Short-Term Assets	$128.8M	$197.3M	$159.3M
YoY Change	-19.15%	23.83%	44.42%
Inventory	$457.0M	$457.0M	$416.9M
Prepaid Expenses
Receivables	$614.3M	$625.2M	$474.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.575B	$1.575B	$1.523B
YoY Change	3.37%	3.36%	33.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$463.5M	$592.1M	$417.3M
YoY Change	11.06%	10.52%	7.71%
Goodwill	$1.928B		$1.890B
YoY Change	1.99%		1.82%
Intangibles
YoY Change
Long-Term Investments	$17.15M	$17.15M	$14.11M
YoY Change	21.58%	-61.1%	-34.88%
Other Assets	$160.9M	$217.5M	$148.7M
YoY Change	8.23%	56.89%	-1.52%
Total Long-Term Assets	$3.153B	$3.153B	$3.064B
YoY Change	2.92%	2.92%	3.43%
TOTAL ASSETS
Total Short-Term Assets	$1.575B	$1.575B	$1.523B
Total Long-Term Assets	$3.153B	$3.153B	$3.064B
Total Assets	$4.728B	$4.728B	$4.587B
YoY Change	3.07%	3.07%	11.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$138.0M	$138.0M	$135.8M
YoY Change	1.64%	1.63%	17.34%
Accrued Expenses	$320.6M	$344.2M	$270.4M
YoY Change	18.59%	18.2%	1.5%
Deferred Revenue	$109.6M		$98.62M
YoY Change	11.15%		11.22%
Short-Term Debt	$12.00M	$0.00	$11.99M
YoY Change	0.11%		-0.04%
Long-Term Debt Due	$12.00M	$12.00M	$12.00M
YoY Change	0.0%	0.0%	0.0%
Total Short-Term Liabilities	$911.8M	$911.8M	$602.8M
YoY Change	51.26%	51.26%	8.41%
LONG-TERM LIABILITIES
Long-Term Debt	$643.4M	$643.4M	$1.164B
YoY Change	-44.73%	-44.73%	-7.53%
Other Long-Term Liabilities	$6.802M	$276.0M	$8.347M
YoY Change	-18.51%	-11.08%	305.59%
Total Long-Term Liabilities	$930.7M	$919.4M	$1.488B
YoY Change	-37.44%	-37.65%	0.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$911.8M	$911.8M	$602.8M
Total Long-Term Liabilities	$930.7M	$919.4M	$1.488B
Total Liabilities	$1.842B	$1.842B	$2.090B
YoY Change	-11.86%	-11.86%	2.7%
SHAREHOLDERS EQUITY
Retained Earnings	$3.080B		$2.833B
YoY Change	8.71%		16.28%
Common Stock	$1.622B		$1.571B
YoY Change	3.28%		3.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.623B		$1.623B
YoY Change	0.0%		0.0%
Treasury Stock Shares	41.84M shares		$41.84M
Shareholders Equity	$2.886B	$2.886B	$2.497B
YoY Change
Total Liabilities & Shareholders Equity	$4.728B	$4.728B	$4.587B
YoY Change	3.07%	3.07%	11.68%

Cashflow Statement

Concept	2021 Q2	2021	2020 Q2
OPERATING ACTIVITIES
Net Income	$195.1M	$474.5M	$177.8M
YoY Change	9.73%	-23.67%	158.43%
Depreciation, Depletion And Amortization	$36.76M	$156.8M	$38.60M
YoY Change	-4.77%	1.23%	-9.39%
Cash From Operating Activities	$226.5M	$736.7M	$330.3M
YoY Change	-31.42%	-8.17%	132.77%
INVESTING ACTIVITIES
Capital Expenditures	-$30.83M	$102.7M	-$21.10M
YoY Change	46.09%	7.74%	-12.81%
Acquisitions		$39.07M
YoY Change		39.97%
Other Investing Activities	-$17.24M	-$41.64M	$17.80M
YoY Change	-196.83%	-43.66%	-190.82%
Cash From Investing Activities	-$48.06M	-$158.5M	-$3.400M
YoY Change	1313.59%	-11.9%	-92.26%
FINANCING ACTIVITIES
Cash Dividend Paid		$226.7M
YoY Change		0.72%
Common Stock Issuance & Retirement, Net		$37.79M
YoY Change		-21.57%
Debt Paid & Issued, Net		$612.0M
YoY Change		-52.34%
Cash From Financing Activities	-114.0M	-$764.6M	-236.4M
YoY Change	-51.76%	140.99%	142.21%
NET CHANGE
Cash From Operating Activities	226.5M	$736.7M	330.3M
Cash From Investing Activities	-48.06M	-$158.5M	-3.400M
Cash From Financing Activities	-114.0M	-$764.6M	-236.4M
Net Change In Cash	64.42M	-$167.9M	90.50M
YoY Change	-28.81%	-153.12%	22525.0%
FREE CASH FLOW
Cash From Operating Activities	$226.5M	$736.7M	$330.3M
Capital Expenditures	-$30.83M	$102.7M	-$21.10M
Free Cash Flow	$257.3M	$634.0M	$351.4M
YoY Change	-26.77%	-10.31%	111.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Entity Address Country EntityAddressCountry	US
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	474643000
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000943819
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	rmd	Reclassifications In Equity Investments ReclassificationsInEquityInvestments
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
CY2021	dei	Entity File Number EntityFileNumber	001-15317
CY2021	dei	Entity Registrant Name EntityRegistrantName	ResMed Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0152841
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	9001 Spectrum Center Blvd.
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92123
CY2021	dei	City Area Code CityAreaCode	858
CY2021	dei	Local Phone Number LocalPhoneNumber	836-5000
CY2021	dei	Security12b Title Security12bTitle	Common Stock, par value $0.004 per share
CY2021	dei	Trading Symbol TradingSymbol	RMD
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Public Float EntityPublicFloat	30662112869
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	145681
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	295278000
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	463156000
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	32138000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	28508000
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	614292000
CY2021Q2	us-gaap	Inventory Net InventoryNet	457033000
CY2020Q2	us-gaap	Inventory Net InventoryNet	416915000
CY2021Q2	us-gaap	Prepaid Taxes PrepaidTaxes	72409000
CY2020Q2	us-gaap	Prepaid Taxes PrepaidTaxes	93484000
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	135745000
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	75261000
CY2021Q2	us-gaap	Assets Current AssetsCurrent	1574757000
CY2020Q2	us-gaap	Assets Current AssetsCurrent	1523459000
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	463490000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	417335000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	128575000
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118348000
CY2021Q2	us-gaap	Goodwill Goodwill	1927901000
CY2020Q2	us-gaap	Goodwill Goodwill	1890324000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	392582000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	448168000
CY2021Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	79904000
CY2020Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	41065000
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	160916000
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	148677000
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	3153368000
CY2020Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	3063917000
CY2021Q2	us-gaap	Assets Assets	4728125000
CY2020Q2	us-gaap	Assets Assets	4587376000
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	138008000
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	135786000
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	320599000
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	270353000
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23585000
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	21263000
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	109611000
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	98617000
CY2021Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	307963000
CY2020Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	64755000
CY2021Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	12000000
CY2020Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	11987000
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	911766000
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	602761000
CY2021Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	91496000
CY2020Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	87307000
CY2021Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	11319000
CY2020Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	13011000
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	114779000
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	101880000
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6802000
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8347000
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	643351000
CY2020Q2	us-gaap	Long Term Debt LongTermDebt	1164133000
CY2021Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	62933000
CY2020Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	112910000
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	930680000
CY2020Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1487588000
CY2021Q2	us-gaap	Liabilities Liabilities	1842446000
CY2020Q2	us-gaap	Liabilities Liabilities	2090349000
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2020Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.004
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.004
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	187484592
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	145648358
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	186723407
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	144887175
CY2021Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	583000
CY2020Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	580000
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1622199000
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1570694000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3079640000
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2832991000
CY2020Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	41836234
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	41836234
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1623256000
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1623256000
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-193487000
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-283982000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	2885679000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	2497027000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4728125000
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4587376000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3196825000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2957013000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2606572000
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1312598000
CY2020	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1189624000
CY2019	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	1069987000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	45127000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49603000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	42514000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1357725000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1239227000
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1112501000
CY2021	us-gaap	Gross Profit GrossProfit	1839100000
CY2020	us-gaap	Gross Profit GrossProfit	1717786000
CY2019	us-gaap	Gross Profit GrossProfit	1494071000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	670387000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	676689000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	645010000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	225284000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	201946000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	180651000
CY2021	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	31078000
CY2020	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	30092000
CY2019	rmd	Amortization Of Acquired Intangible Assets1 AmortizationOfAcquiredIntangibleAssets1	32424000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	8673000
CY2019	us-gaap	Restructuring Charges RestructuringCharges	9401000
CY2020	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	-600000
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	41199000
CY2019	rmd	Acquisition Related Expenses AcquisitionRelatedExpenses	6123000
CY2021	us-gaap	Operating Expenses OperatingExpenses	935422000
CY2020	us-gaap	Operating Expenses OperatingExpenses	908127000
CY2019	us-gaap	Operating Expenses OperatingExpenses	914808000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	903678000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	809659000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	579263000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	362000
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	1021000
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	2299000
CY2021	us-gaap	Interest Expense InterestExpense	23989000
CY2020	us-gaap	Interest Expense InterestExpense	40377000
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	57100000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-30973000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000
CY2019	us-gaap	Interest Expense InterestExpense	36156000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11205000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-25058000
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-15833000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14816000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12157000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10726000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20016000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-76571000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-60416000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	883662000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	733088000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	518847000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	409157000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111414000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	114255000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	404592000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.27
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.31
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.83
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.24
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.27
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.80
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.56
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.56
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.48
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145313000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	144338000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143111000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146451000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145652000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	144484000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	404592000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	90495000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-30973000
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-28681000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	565000000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	590701000
CY2021	us-gaap	Dividends Dividends	226713000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	2885679000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	404592000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	57559000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	52073000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	375911000
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	2058980000
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12330000
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-28101000
CY2020	us-gaap	Dividends Dividends	225093000
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	24365000
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	22845000
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	52063000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-28681000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	404592000
CY2019	us-gaap	Dividends Dividends	211712000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	2072193000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	156758000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	154850000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	150795000
CY2021	rmd	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	34760000
CY2020	rmd	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	26523000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	63927000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	2497027000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19987000
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-46058000
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	28197000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3954000
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-50207000
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	33834000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	36156000
CY2021	rmd	Noncash Part Of Acquisition Fair Value Of Assets Acquired NoncashPartOfAcquisitionFairValueOfAssetsAcquired	16671000
CY2020	rmd	Noncash Part Of Acquisition Fair Value Of Assets Acquired NoncashPartOfAcquisitionFairValueOfAssetsAcquired	14919000
CY2019	rmd	Noncash Part Of Acquisition Fair Value Of Assets Acquired NoncashPartOfAcquisitionFairValueOfAssetsAcquired	429522000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	1543000
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	63927000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	90495000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11205000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-25058000
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-15833000
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	-14515000
CY2020	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	14519000
CY2019	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	15007000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	8673000
CY2019	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	1909000
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7000
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-286000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	129195000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-54383000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18013000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21954000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	69881000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	84188000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58154000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58999000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	47575000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	210708000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-23424000
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-27278000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	736718000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	802255000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	459051000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	102712000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	95330000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	68710000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	48182000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	14114000
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10608000
CY2020	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	14397000
CY2019	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	264000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-158462000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-179861000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1075706000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	37790000
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	463156000
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	147128000
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	188701000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	295278000
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	463156000
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	8632000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	39067000
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	27910000
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	951383000
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	21788000
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	31616000
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	46717000
CY2021	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-19219000
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	36727000
CY2021	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-50209000
CY2020	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-46061000
CY2019	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-28104000
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	22844000
CY2021	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	3500000
CY2020	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	302000
CY2019	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	909000
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	90000000
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1190000000
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1519230000
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	612000000
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1284012000
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	711745000
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	226713000
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	225093000
CY2019	us-gaap	Payments Of Dividends PaymentsOfDividends	211712000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-764632000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-317286000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	580643000
CY2021	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	18498000
CY2020	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	10920000
CY2019	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-5561000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-167878000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	316028000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-41573000
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	147128000
CY2020	rmd	Deferred Payment Obligations For Acquisitions DeferredPaymentObligationsForAcquisitions	-408000
CY2019	rmd	Deferred Payment Obligations For Acquisitions DeferredPaymentObligationsForAcquisitions	7242000
CY2020	rmd	Business Acquisition Contingent Consideration Recognized Liability BusinessAcquisitionContingentConsiderationRecognizedLiability	3500000
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	43567000
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	27910000
CY2019	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	951383000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	221359000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	180359000
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	242860000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	23989000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	40377000
CY2019	us-gaap	Depreciation Depreciation	65900000
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	4292000
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	265217000
CY2021	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	24671000
CY2020	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	20375000
CY2019	rmd	Goodwill Acquired During Period Increase Decrease GoodwillAcquiredDuringPeriodIncreaseDecrease	794320000
CY2021	rmd	Deferred Payment Obligations For Acquisitions DeferredPaymentObligationsForAcquisitions	-3768000
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	109611000
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	98617000
CY2021Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	91496000
CY2020Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	87307000
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2020Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	495200000
CY2021	us-gaap	Depreciation Depreciation	78400000
CY2020	us-gaap	Depreciation Depreciation	65600000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	556400000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	448168000
CY2021Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	155419000
CY2020Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	128096000
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4647000
CY2020Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2807000
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	296967000
CY2020Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	286012000
CY2021Q2	us-gaap	Inventory Net InventoryNet	457033000
CY2020Q2	us-gaap	Inventory Net InventoryNet	416915000
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1085629000
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	969166000
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	622139000
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	551831000
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	463490000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	417335000
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020Q2	us-gaap	Goodwill Goodwill	1890324000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	24671000
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	12906000
CY2021Q2	us-gaap	Goodwill Goodwill	1927901000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	392582000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	75009000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	58028000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	54211000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	49741000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	44556000
CY2021Q2	rmd	Marketable Equity Investments Fair Value MarketableEquityInvestmentsFairValue	29084000
CY2021Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	23002000
CY2020Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	30033000
CY2021Q2	us-gaap	Equity Method Investments EquityMethodInvestments	17154000
CY2020Q2	us-gaap	Equity Method Investments EquityMethodInvestments	14109000
CY2021Q2	rmd	Equity Investments Total By Measurement Category EquityInvestmentsTotalByMeasurementCategory	69240000
CY2020Q2	rmd	Equity Investments Total By Measurement Category EquityInvestmentsTotalByMeasurementCategory	44142000
CY2020Q2	rmd	Equity Investments EquityInvestments	44142000
CY2021	rmd	Additional Equity Investments AdditionalEquityInvestments	21788000
CY2021	rmd	Observable Price Adjustments On Non Marketable Equity Securities ObservablePriceAdjustmentsOnNonMarketableEquitySecurities	1000000
CY2021	rmd	Ongoing Mark To Market Adjustments On Marketable Equity Securities OngoingMarkToMarketAdjustmentsOnMarketableEquitySecurities	13515000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11205000
CY2021Q2	rmd	Equity Investments EquityInvestments	69240000
CY2019Q2	rmd	Equity Investments EquityInvestments	52103000
CY2020	rmd	Additional Equity Investments AdditionalEquityInvestments	31616000
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	-14519000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-25058000
CY2020Q2	rmd	Equity Investments EquityInvestments	44142000
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12261000
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12482000
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	320599000
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	270353000
CY2021Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	22032000
CY2020Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	21132000
CY2021Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	21246000
CY2020Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	18740000
CY2020Q2	rmd	Accrued Logistics And Occupancy Expenses Current AccruedLogisticsAndOccupancyExpensesCurrent	6350000
CY2021Q2	rmd	Accrued Inventory In Transit AccruedInventoryInTransit	7146000
CY2020Q2	rmd	Accrued Inventory In Transit AccruedInventoryInTransit	21679000
CY2021Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	26542000
CY2020Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	26627000
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	199917000
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	148383000
CY2021Q2	rmd	Accrued Liability On Receivables Current AccruedLiabilityOnReceivablesCurrent	8163000
CY2020Q2	rmd	Accrued Liability On Receivables Current AccruedLiabilityOnReceivablesCurrent	6647000
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	8338000
CY2020Q2	us-gaap	Interest Payable Current InterestPayableCurrent	8313000
CY2021Q2	rmd	Accrued Logistics And Occupancy Expenses Current AccruedLogisticsAndOccupancyExpensesCurrent	14954000
CY2020Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	21132000
CY2019Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	19625000
CY2021	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	14366000
CY2020	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	14167000
CY2021	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	14858000
CY2020	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	12229000
CY2021	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-1392000
CY2020	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	431000
CY2021Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	22032000
CY2020Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	21132000
CY2021Q2	rmd	Short Term Borrowings Gross ShortTermBorrowingsGross	12000000
CY2020Q2	rmd	Short Term Borrowings Gross ShortTermBorrowingsGross	12000000
CY2020Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	13000
CY2021Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	12000000
CY2020Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	11987000
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	646000000
CY2020Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1168000000
CY2021Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2649000
CY2020Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	3867000
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	643351000
CY2020Q2	us-gaap	Long Term Debt LongTermDebt	1164133000
CY2021Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	655351000
CY2020Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1176120000
CY2021	rmd	Debt To Consolidated Ebitda Ratio DebtToConsolidatedEbitdaRatio	3.50
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	35500000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	26500000
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	158247000
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	27272000
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	23163000
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	16680000
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	13564000
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	13168000
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	64400000
CY2021Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	19883000
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	138364000
CY2021Q2	rmd	Lessee Operating Lease Lease Not Yet Commenced Commitments LesseeOperatingLeaseLeaseNotYetCommencedCommitments	600000
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y6M
CY2021	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	229000
CY2020	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	265000
CY2019	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	285000
CY2021	rmd	Number Of Offerings For Employee Stock Purchase Plan NumberOfOfferingsForEmployeeStockPurchasePlan	2
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	97.01
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M12D
CY2021Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	804000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	82.11
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y2M12D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1050000
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y1M6D
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.030
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.032
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	27734000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	24104000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	36130000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	51663000
CY2021	us-gaap	Sales Type Lease Lease Income SalesTypeLeaseLeaseIncome	9758000
CY2020	us-gaap	Sales Type Lease Lease Income SalesTypeLeaseLeaseIncome	13457000
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	93431000
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	87874000
CY2021	rmd	Lessor Lease Revenue LessorLeaseRevenue	103189000
CY2020	rmd	Lessor Lease Revenue LessorLeaseRevenue	101331000
CY2021Q2	us-gaap	Sales Type Lease Lease Receivable SalesTypeLeaseLeaseReceivable	8026000
CY2020Q2	us-gaap	Sales Type Lease Lease Receivable SalesTypeLeaseLeaseReceivable	7697000
CY2021Q2	rmd	Sales Type Lease Lease Prepaid Taxes And Other Noncurrent Assets SalesTypeLeaseLeasePrepaidTaxesAndOtherNoncurrentAssets	6214000
CY2020Q2	rmd	Sales Type Lease Lease Prepaid Taxes And Other Noncurrent Assets SalesTypeLeaseLeasePrepaidTaxesAndOtherNoncurrentAssets	6957000
CY2021Q2	us-gaap	Sales Type Lease Net Investment In Lease SalesTypeLeaseNetInvestmentInLease	14240000
CY2020Q2	us-gaap	Sales Type Lease Net Investment In Lease SalesTypeLeaseNetInvestmentInLease	14654000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6035000
CY2021Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears	5173000
CY2021Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears	1699000
CY2021Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears	174000
CY2021Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Five Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears	172000
CY2021Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount	1356000
CY2021Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	14240000
CY2014Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	20000000.0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	96.37
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y8M12D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8900000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	31200000
CY2021Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	15596000
CY2021Q2	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths	8378000
CY2014Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	20000000.0
CY2021Q2	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	12900000
CY1997Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY1997Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P7Y
CY2021Q2	rmd	Reduction In Number Of Shares Of Common Stock Available For Issuance ReductionInNumberOfSharesOfCommonStockAvailableForIssuance	2.8
CY2021Q2	rmd	Maximum Number Of Shares Subject To Awards Granted MaximumNumberOfSharesSubjectToAwardsGranted	3000000
CY2021Q2	rmd	Number Of Common Stock Granted NumberOfCommonStockGranted	4500000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	59600000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	56800000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	52300000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1068000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	89.05
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M24D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	56000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	210.18
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	64000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	62.05
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1060000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	15100000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	158500000
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	132100000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	157600000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	553315000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.31
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.25
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.23
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	63927000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	57559000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52073000
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	23346000
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	39534000
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	26658000
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	40581000
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	18025000
CY2019	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	25415000
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	94300000
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	141000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	164000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	474505000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	621674000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	404592000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145313000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	144338000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143111000
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1138000
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1314000
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1373000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146451000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145652000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	144484000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.27
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.31
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.83
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.24
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.27
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.80
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	883662000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	733088000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	518847000
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-13674000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-29876000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16587000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-115109000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9790000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	28658000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	9041000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6898000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7595000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	531812000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	124602000
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	127540000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	425744000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	141290000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	163793000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-22791000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-13000000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-30456000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4205000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3335000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-5408000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	10409000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-13541000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-753000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1331000
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1712000
CY2021	rmd	Other Component Of Other Operating Income Expense OtherComponentOfOtherOperatingIncomeExpense	1054000
CY2020	rmd	Other Component Of Other Operating Income Expense OtherComponentOfOtherOperatingIncomeExpense	1031000
CY2019	rmd	Other Component Of Other Operating Income Expense OtherComponentOfOtherOperatingIncomeExpense	2569000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14816000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12157000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10726000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	71867000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	60548000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-34468000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	811795000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	672540000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-49538000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	409157000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111414000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	114255000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	185569000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	153949000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	108958000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	4836000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3563000
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2186000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	20257000
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	13595000
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	12953000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3785000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7216000
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1118000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-12130000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-20935000
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	25045000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	7210000
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	4026000
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	7806000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-4498000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-20696000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-11534000
CY2021	rmd	Effective Income Tax Rate Reconciliation Uncertain Tax Position Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionAmount	248773000
CY2019	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	6038000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	17859000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	5938000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	5439000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	409157000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111414000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	114255000
CY2021Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	79904000
CY2020Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	41065000
CY2021Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	11319000
CY2020Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	13011000
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	68585000
CY2020Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	28054000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	30080000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	21272000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	13753000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	9295000
CY2021Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	11734000
CY2020Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	9129000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	4149000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	3585000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	7334000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	6594000
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33377000
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38035000
CY2021Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6912000
CY2020Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	10864000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6080000
CY2021Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	17839000
CY2020Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	15343000
CY2021Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	58789000
CY2020Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	39195000
CY2021Q2	rmd	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	25751000
CY2021Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-5851000
CY2020Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-3006000
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	209947000
CY2020Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	156341000
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13106000
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16891000
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	196841000
CY2020Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	139450000
CY2021Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	104563000
CY2020Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	111396000
CY2021Q2	rmd	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	23693000
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	128256000
CY2020Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	111396000
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	68585000
CY2020Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	28054000
CY2021	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	33600000
CY2021	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.23
CY2020	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	43800000
CY2020	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.30
CY2019	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	20300000
CY2019	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.14
CY2021	rmd	Tax Cuts And Jobs Act Payable Period Of Additional Tax Expense TaxCutsAndJobsActPayablePeriodOfAdditionalTaxExpense	P8Y
CY2021Q2	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	3200000000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	395300000
CY2021Q2	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	47500000
CY2021Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	248700000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	395300000
CY2021	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	146600000
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3196825000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2957013000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2606572000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	156758000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	154850000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2606572000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	150795000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3196825000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2957013000
CY2020Q2	us-gaap	Noncurrent Assets NoncurrentAssets	463490000
CY2019Q2	us-gaap	Noncurrent Assets NoncurrentAssets	417335000
CY2021	rmd	Receivables Sold With Limited Recourse ReceivablesSoldWithLimitedRecourse	153000000.0
CY2020	rmd	Receivables Sold With Limited Recourse ReceivablesSoldWithLimitedRecourse	154500000
CY2021Q2	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	30200000
CY2021	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	8200000
CY2021	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	8200000
CY2020Q2	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	22800000
CY2020	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	6600000
CY2021Q2	us-gaap	Purchase Obligation PurchaseObligation	1100839000
CY2021Q2	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	1099419000
CY2021Q2	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	994000
CY2021Q2	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	426000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0
CY2020	us-gaap	Restructuring Costs RestructuringCosts	0
CY2021	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(20) Litigation Settlement Expenses</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We did </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">t recognize any material litigation settlement expenses during the years ended June 30, 2021 and 2020.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the year ended June 30, 2019 we recognized litigation settlement expenses of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">41.2</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million associated with a tentative agreement with the United States Department of Justice to civilly resolve the investigation of certain marketing practices. We finalized the settlement in December 2019 and announced it in January 2020 on terms that were consistent with our prior reserve. The settlement amount consisted of the payment to the United States and to various states that joined the action, as well as attorneys’ fees and other costs to the private litigants that filed the suits that the Department of Justice pursued. We also entered into a corporate integrity agreement with the Office of the Inspector General of the U.S. Department of Health and Human Services with accompanying oversight of our sales and marketing practices in the United States for five years. </span>
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	41200000

Files In Submission

Name	View Source	Status
0000943819-21-000017-index-headers.html	Edgar Link	pending
0000943819-21-000017-index.html	Edgar Link	pending
0000943819-21-000017.txt	Edgar Link	pending
0000943819-21-000017-xbrl.zip	Edgar Link	pending
c819-20210630.xsd	Edgar Link	pending
c819-20210630x10k.htm	Edgar Link	pending
c819-20210630x10kg001.jpg	Edgar Link	pending
c819-20210630x10k_htm.xml	Edgar Link	completed
c819-20210630xex10_10.htm	Edgar Link	pending
c819-20210630xex10_11.htm	Edgar Link	pending
c819-20210630xex21_1.htm	Edgar Link	pending
c819-20210630xex23_1.htm	Edgar Link	pending
c819-20210630xex31_1.htm	Edgar Link	pending
c819-20210630xex31_2.htm	Edgar Link	pending
c819-20210630xex32_1.htm	Edgar Link	pending
c819-20210630_cal.xml	Edgar Link	unprocessable
c819-20210630_def.xml	Edgar Link	unprocessable
c819-20210630_lab.xml	Edgar Link	unprocessable
c819-20210630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMD
RESMED INC Stock $rmd

2021 Q2 Form 10-K Financial Statement

#000094381921000017 Filed on August 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMD RESMED INC Stock $rmd

2021 Q2 Form 10-K Financial Statement

#000094381921000017 Filed on August 17, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMD
RESMED INC Stock $rmd